Back to trial detailsIntake questionnaire
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
Applying to Yale-New Haven Hospital North Haven Medical Center · North Haven, Connecticut
Answer a few short questions to share with the research team.
0 of 3 answered